Jinlu Dai

5.8k total citations
58 papers, 4.5k citations indexed

About

Jinlu Dai is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinlu Dai has authored 58 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 32 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinlu Dai's work include Bone health and treatments (24 papers), Prostate Cancer Treatment and Research (18 papers) and Bone Metabolism and Diseases (12 papers). Jinlu Dai is often cited by papers focused on Bone health and treatments (24 papers), Prostate Cancer Treatment and Research (18 papers) and Bone Metabolism and Diseases (12 papers). Jinlu Dai collaborates with scholars based in United States, China and Japan. Jinlu Dai's co-authors include Evan T. Keller, Zhi Yao, Jill M. Keller, Atsushi Mizokami, Yi Lü, Christopher L. Hall, Russell S. Taichman, Kenneth J. Pienta, Laurie K. McCauley and June Escara‐Wilke and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Jinlu Dai

57 papers receiving 4.4k citations

Peers

Countries citing papers authored by Jinlu Dai

Since Specialization

Citations

This map shows the geographic impact of Jinlu Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinlu Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinlu Dai more than expected).

Fields of papers citing papers by Jinlu Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinlu Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinlu Dai. The network helps show where Jinlu Dai may publish in the future.

Co-authorship network of co-authors of Jinlu Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Jinlu Dai. A scholar is included among the top collaborators of Jinlu Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinlu Dai. Jinlu Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate 2025 ·Neoplasia ·Greg Shelley, (unknown), Tyler D. Robinson, Jinlu Dai, (unknown), Evan T. Keller	0
2	Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells 2020 ·Molecular Cancer Research ·(unknown), Greg Shelley, Jinlu Dai, (unknown), Hui Jiang, Atsushi Mizokami, Evan T. Keller	33
3	Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone 2019 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Fuhao Wang, Qiuyan Chen, Jinlu Dai, June Escara‐Wilke, Evan T. Keller, Johann Zimmermann, Ni Hong, Yi Lü, Jian Zhang	30
4	Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance 2017 ·Molecular Cancer Research ·Mi Zhang, (unknown), Jinlu Dai, Jill M. Keller, June Escara‐Wilke, Atsushi Mizokami, Evan T. Keller	10
5	Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression 2017 ·Molecular Cancer Research ·Yuan Jiang, Jinlu Dai, Zhi Yao, Greg Shelley, Evan T. Keller	27
6	Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling 2017 ·Chinese Journal of Cancer ·(unknown), Lihui Wang, Atsushi Mizokami, Junlin Shi, Chunlin Zou, Jinlu Dai, Evan T. Keller, Yi Lü, Jian Zhang	68
7	Tumor-Induced Pressure in the Bone Microenvironment Causes Osteocytes to Promote the Growth of Prostate Cancer Bone Metastases 2015 ·Cancer Research ·Joseph L. Sottnik, Jinlu Dai, Honglai Zhang, Brittany Campbell, Evan T. Keller	114
8	Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer 2015 ·Clinical Cancer Research ·Di Cui, Jinlu Dai, Jill M. Keller, Atsushi Mizokami, Shujie Xia, Evan T. Keller	80
9	Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone 2013 ·Molecular Cancer Research ·Yuan Jiang, Jinlu Dai, Honglai Zhang, (unknown), Jill M. Keller, Katherine J. Escott, Hitesh J. Sanganee, Zhi Yao, Laurie K. McCauley, Evan T. Keller	26
10	Cabozantinib Inhibits Prostate Cancer Growth and Prevents Tumor-Induced Bone Lesions 2013 ·Clinical Cancer Research ·Jinlu Dai, Honglai Zhang, (unknown), Jill M. Keller, Kenneth M. Kozloff, Dana T. Aftab, Frauke Schimmöller, Evan T. Keller	79
11	Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells 2011 ·Clinical Cancer Research ·(unknown), (unknown), Chuanhong Liao, Jinlu Dai, Evan T. Keller, Hikmat Al‐Ahmadie, (unknown), Peter V. Usatyuk, (unknown), Gladell P. Paner, Soheil Yala, Gustavo M. Cervantes, Viswanathan Natarajan, Ravi Salgia, Edwin M. Posadas	28
12	CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer 2009 ·The Prostate ·(unknown), Atsushi Mizokami, Kouji Izumi, Kazutaka Narimoto, Takashi Shima, Jian Zhang, Jinlu Dai, Evan T. Keller, Mikio Namiki	27
13	Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms 2008 ·Cancer Research ·Jinlu Dai, Christopher L. Hall, June Escara‐Wilke, Atsushi Mizokami, Jill M. Keller, Evan T. Keller	119
14	Aldehyde dehydrogenase is a marker of prostate cancer stem cell-like cells in cell lines 2007 ·Cancer Research ·Chunyan Yu, Zhi Yao, Jinlu Dai, Xiaohua Zhang, June Escara‐Wilke, Evan T. Keller	1
15	New trends in the treatment of bone metastasis 2007 ·Journal of Cellular Biochemistry ·Evan T. Keller, Jinlu Dai, June Escara‐Wilke, Christopher L. Hall, Kathleen M. Woods Ignatoski, Russell S. Taichman, Jill M. Keller	18
16	Alzheimer Aβ Vaccination of Rhesus Monkeys (Macaca Mulatta) 2004 ·Alzheimer Disease & Associated Disorders ·Sam Gandy, (unknown), Cynthia A. Lemere, Frank L. Heppner, (unknown), Adriano Aguzzi, William B. Ershler, Jinlu Dai, Paul Fraser, Peter St George‐Hyslop, David M. Holtzman, Lary C. Walker, Evan T. Keller	23
17	Mechanisms of Unexplained Anemia in the Nursing Home 2004 ·Journal of the American Geriatrics Society ·Andrew Artz, Dean Fergusson, Paul J. Drinka, (unknown), (unknown), (unknown), Felix A. Silverstone, Mark McCamish, Jinlu Dai, Evan T. Keller, William B. Ershler	80
18	Osteoprotegerin inhibits prostate cancer–induced osteoclastogenesis and prevents prostate tumor growth in the bone 2001 ·Journal of Clinical Investigation ·Jian Zhang, Jinlu Dai, Yinghua Qi, (unknown), Peter Smith, C. Strayhorn, Atsushi Mizokami, Zheng Fu, J.J. Westman, Evan T. Keller	374
19	Bone metastatic LNCaP‐derivative C4‐2B prostate cancer cell line mineralizes in vitro 2001 ·The Prostate ·Din‐Lii Lin, Catherine P. Tarnowski, (unknown), Jinlu Dai, (unknown), Avni H. Patel, M.D. Morris, Evan T. Keller	128
20	Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice 2000 ·Journal of Clinical Investigation ·Jinlu Dai, Din‐Lii Lin, Jian Zhang, (unknown), Peter Smith, Jill Murtha, Zheng Fu, Zhi Yao, Yinghua Qi, Evan T. Keller	127

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact